Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 5Dermatologic 1Breast 1

Conditions

Melanoma 49Carcinoma, Basal Cell 12Neoplasm Metastasis 9Lymphoma, T-Cell, Cutaneous 9Skin Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Lymphoma, T-Cell 5Colorectal Neoplasms 5Carcinoma, Merkel Cell 5Uveal Melanoma 4Uterine Cervical Neoplasms 4Mycosis Fungoides 4Lymphoma 4Lung Neoplasms 4Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 3Sarcoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Keratosis, Actinic 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Sezary Syndrome 2Prostatic Neoplasms 2

Interventions

pembrolizumab 8Nivolumab 4fludarabine 2Cyclophosphamide 2sonidegib 1obinutuzumab 1methyl 5-aminolevulinate 1lutetium Lu 177 dotatate 1fludarabine phosphate 1durvalumab 1daromun 1cabozantinib 1avelumab 1atezolizumab 1advexin 1Tomography, Optical Coherence 1Therapeutics 1Taxes 1Specimen Handling 1Radiotherapy 1ProMune 1Pemetrexed 1Paclitaxel 1Oncolytic Virotherapy 1Mesna 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Lutetium-177 1Interleukin-2 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Biopsy × Dermatologic × Clear all
NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡